Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008
BOSTON SCIENTIFIC CORPORATION NON-GAAP NET (LOSS) INCOME AND NET (LOSS) INCOME PER SHARE RECONCILIATIONS
(Unaudited)
An explanation of the ways in which Boston Scientific management uses
these non-GAAP measures to evaluate its business, the substance behind
Boston Scientific management's decision to use these non-GAAP measures,
the material limitations associated with the use of these non-GAAP
measures, the manner in which Boston Scientific management compensates for
those limitations, and the substantive reasons why Boston Scientific
management believes that these non-GAAP measures provide useful
information to investors is included in the exhibit labeled "Use of Non-
GAAP Financial Measures.
Three Months Ended Three Months Ended
December 31, 2007 December 31, 2006
Net Impact per Impact per
income diluted Net diluted
In millions, except per share data (loss) share income share
GAAP results $(458) $(0.31) $277 $0.19
Non-GAAP adjustments:
Acquisition and divestiture-
related charges 211 0.14 23 0.02
Restructuring charges 131 0.09
Litigation-related charges 294 0.20
Amortization expense 177 0.12 142 0.09
Adjusted results $355 $0.24 (1) $442 $0.30
(1) Calculated by assuming stock-based dilution of 9.0 million shares
Three Months Ended
December 31,
2007 2006'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
(Date:5/20/2013)... Mass. , May 20, 2013 Flexion ... Frederick W. Driscoll to its management ... than 30 years of financial management experience with biotechnology ... Flexion, Mr. Driscoll was chief financial officer for Novavax ... team that secured more than $250 million through a ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his colleagues ... Institute have helped pioneer many breakthroughs in the ... the past three decades, from new disease-fighting medications to ... stent implantation. , Today, AGH officials announced that the ... the study of a novel, first-of-its kind investigational device ...
(Date:5/20/2013)... Recognizing exciting and innovative scientific research, ... 2013 Class of Young Professors. Over the ... outstanding international group with more than $824,000 to ... meet global challenges. , The DuPont Young Professor ... untenured research faculty working in areas of interest ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today ... exploration of hospital costs across the United States ... recent release of “Medicare Provider Charge Data,” a dataset ... from the Centers for Medicare & Medicaid Services. , ... hospitals across the country has sparked considerable controversy; however, ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3Kitware Enables Interactive Exploration of CMS Medicare Data 2[0] Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer[0] Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device[0] DuPont Celebrates Scientific Innovation by Recognizing Young Professors[0] Kitware Enables Interactive Exploration of CMS Medicare Data
... expansion of PROVENT(R) Sleep Apnea Therapy in Limited ... Inc. a privately-held, medical device company, focused on ... the appointment of John McCutcheon as President and ... company also announced that current CEO Jeffrey Nugent ...
... Group (OTC Bulletin Board: SNBP) is pleased to ... Director of Marketing.Ms. Tan joins Sinobiopharma from Organon ... China-based Unit Marketing Director for Organon, which was ... Tan held senior marketing management roles at China ...
... Kiadis,Pharma reported preliminary clinical data on ATIR(TM) ... Data was presented by the,company,s principal investigator ... Symposium at the Annual European Bone Marrow ... March 30, 2009. Only the 6,highest ranked ...
Cached Biology Technology:Ventus Medical Appoints John McCutcheon as President and CEO 2Sinobiopharma, Inc. Appoints New Director of Marketing 2Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations 2(Date:5/17/2013)... An international team of scientists using ... cell movement inside a living frog embryo in greater ... method to advance biological research and the search for ... and the Karlsruher Institut fr Technologie in Germany, in ... Department of Energy,s Argonne National Laboratory, released the most ...
(Date:5/16/2013)... African-American adults living closer to a fast food ... those who lived further away from fast food, according ... Cancer Center, and this association was particularly strong among ... study published online in the American Journal of ... proximity to a fast food restaurant, and among lower-income ...
(Date:5/16/2013)... BOSTON The endothelium, the cellular layer lining ... just a few hundred nanometers in thickness, this ... stretch and tissue compression to create a unique ... necessary to partition tissues from the body,s circulatory ... when the barrier must be physically breached ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4... to attend and cover the 2010 International Conference on ... 2010, at the Hyatt Regency, Atlanta, Georgia. The ... Control and Prevention (CDC), the American Society for Microbiology, ... of Public Health Laboratories and the World Health Organization. ...
... Coral reefs kaleidoscopes of pink anemones and silver sharks ... most endangered, say marine scientists. As global warming raises ... "coral bleaching." And pumping large amounts of carbon dioxide into ... corals and the fish that depend on them for food ...
... 2010 -- In the time before Columbus sailed the ocean ... drought conditions in Europe and North America that may be ... in the American West. A new study from the ... Nia-like sea surface temperatures in the central Pacific and droughts ...
Cached Biology News:2010 International Conference on Emerging Infectious Diseases 2A tale of two atolls 2A tale of two atolls 3A tale of two atolls 4A cooler Pacific may have severely affected medieval Europe, North America 2ID clarifier: platform...
StemSep Anti-Phycoertherin Tetrameric Antibody Complexes, 2 mL for labeling 1x10 9 cells. Cross-linking Reagent for StemSep Separations of Cells Labeled with PE-conjugated Antibody....
... The PROTEAN II xi multi-cell is for ... with efficient cooling capabilities. The PROTEAN II xi ... length, comb, type of glass plates, and cooling ... be converted to the PROTEAN II XL multi-cell ...
F40 piston seals are supplied as 2 seals with a seal tool to service one F40 pump of a BioLogic DuoFlow workstation....
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |